A novel annexin V derivative (Cys-Annexin V) with a single cysteine residue at its C-terminal has been developed and successfully labeled site-specifically with 18F-FBEM. 18F-FBEM was synthesized by coupling 18F-fluorobenzoic acid (18F-FBA) with N-(2-aminoethyl)maleimide using optimized reaction conditions. The yield of 18F-FBEM-Cys-Annexin V was 71.5% ± 2.0% (n = 4, based on the starting 18F-FBEM, non-decay corrected). The radiochemical purity of 18F-FBEM-Cys-Annexin V was >95%. The specific radioactivities of 18F-FBEM and 18F-FBEM-Cys-Annexin V were >150 and 3.17 GBq/µmol, respectively. Like the 1st generation 18F-SFB-Annexin V, the novel 18F-FBEM-Cys-Annexin V mainly shows renal and to a lesser extent, hepatobiliary excretion in normal mice. In rat hepatic apoptosis models a 3.88 ± 0.05 (n = 4, 1 h) and 10.35 ± 0.08 (n = 4, 2 h) increase in hepatic uptake of 18F-FBEM-Cys-Annexin V compared to normal rats was observed after injection via the tail vein. The liver uptake ratio (treated/control) at 2 h p.i. as measured via microPET correlated with the ratio of apoptotic nuclei in liver observed using TUNEL histochemistry, indicating that the novel 18F-FBEM-Cys-Annexin V is a potential apoptosis imaging agent.
我们开发了一种新型附件素 V 衍
生物(Cys-Annexin V),其 C 端只有一个半胱
氨酸残基,并成功地用 18F-FB
EM 进行了位点特异性标记。18F-FB
EM 是由 18F-
氟苯甲酸(18F-FBA)与 N-(2-
氨基乙基)马来
酰亚胺在优化的反应条件下偶联合成的。18F-FB
EM-Cys-Annexin V 的产率为 71.5% ± 2.0%(n = 4,基于起始 18F-FB
EM,非衰变校正)。18F-FB
EM-Cys-Annexin V 的放射
化学纯度大于 95%。18F-FB
EM 和 18F-FB
EM-Cys-Annexin V 的比放射活性分别大于 150 GBq/µmol 和 3.17 GBq/µmol。与第一代 18F-SFB-Annexin V 一样,新型 18F-FB
EM-Cys-Annexin V 在正常小鼠体内主要通过肾脏排泄,其次是肝胆排泄。在大鼠肝细胞凋亡模型中,经尾静脉注射 18F-FB
EM-Cys-Annexin V 后,与正常大鼠相比,肝摄取量分别增加了 3.88 ± 0.05(n = 4,1 小时)和 10.35 ± 0.08(n = 4,2 小时)。通过 microPET 测定的肝脏摄取比率(处理/对照)与使用 TUNEL 组织
化学法观察到的肝脏凋亡细胞核比率相关,表明新型 18F-FB
EM-Cys-Annexin V 是一种潜在的细胞凋亡成像剂。